RU2018135107A3 - - Google Patents

Download PDF

Info

Publication number
RU2018135107A3
RU2018135107A3 RU2018135107A RU2018135107A RU2018135107A3 RU 2018135107 A3 RU2018135107 A3 RU 2018135107A3 RU 2018135107 A RU2018135107 A RU 2018135107A RU 2018135107 A RU2018135107 A RU 2018135107A RU 2018135107 A3 RU2018135107 A3 RU 2018135107A3
Authority
RU
Russia
Application number
RU2018135107A
Other languages
Russian (ru)
Other versions
RU2771757C2 (ru
RU2018135107A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018135107A publication Critical patent/RU2018135107A/ru
Publication of RU2018135107A3 publication Critical patent/RU2018135107A3/ru
Application granted granted Critical
Publication of RU2771757C2 publication Critical patent/RU2771757C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2018135107A 2016-03-08 2017-01-30 Биомаркеры травматического повреждения головного мозга RU2771757C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1603967.9A GB201603967D0 (en) 2016-03-08 2016-03-08 Biomarkers of traumatic brain injury
GB1603967.9 2016-03-08
PCT/GB2017/050231 WO2017153710A1 (en) 2016-03-08 2017-01-30 Biomarkers of traumatic brain injury

Publications (3)

Publication Number Publication Date
RU2018135107A RU2018135107A (ru) 2020-04-08
RU2018135107A3 true RU2018135107A3 (enExample) 2020-12-14
RU2771757C2 RU2771757C2 (ru) 2022-05-11

Family

ID=

Also Published As

Publication number Publication date
NZ782016A (en) 2025-07-25
CN110291210A (zh) 2019-09-27
ES2967073T3 (es) 2024-04-25
AU2025263788A1 (en) 2025-11-27
GB201603967D0 (en) 2016-04-20
EP3712280A1 (en) 2020-09-23
JP2024041804A (ja) 2024-03-27
PL3712277T3 (pl) 2025-02-10
ZA201805982B (en) 2022-01-26
US20230313300A1 (en) 2023-10-05
EP4582559A2 (en) 2025-07-09
AU2017231845A1 (en) 2018-09-13
ES2987237T3 (es) 2024-11-14
ES3032995T3 (en) 2025-07-29
EP4257705A2 (en) 2023-10-11
EP4257705B1 (en) 2025-04-23
AU2023282212B2 (en) 2025-10-16
CN109415769A (zh) 2019-03-01
AU2023282212A1 (en) 2024-01-04
EP4403649B1 (en) 2026-04-15
EP3574117B1 (en) 2023-08-16
EP3712277B1 (en) 2024-06-12
EP4257705A3 (en) 2024-01-17
KR20190111967A (ko) 2019-10-02
CN110291210B (zh) 2024-05-28
JP2025098112A (ja) 2025-07-01
JP7413455B2 (ja) 2024-01-15
PL4257705T3 (pl) 2025-08-18
US10563262B2 (en) 2020-02-18
UA127918C2 (uk) 2024-02-14
JP7132224B2 (ja) 2022-09-06
US20200385808A1 (en) 2020-12-10
KR20180118670A (ko) 2018-10-31
JP2019509044A (ja) 2019-04-04
EP3426796B1 (en) 2023-09-06
EP4582559A3 (en) 2025-10-08
EP4403649C0 (en) 2026-04-15
US20230295726A1 (en) 2023-09-21
EP4257705C0 (en) 2025-04-23
EP3712280B8 (en) 2023-09-13
EP3712277A1 (en) 2020-09-23
US20180127828A1 (en) 2018-05-10
CN109415769B (zh) 2022-09-30
EP4403649A3 (en) 2024-10-30
JP7654769B2 (ja) 2025-04-01
KR102729795B1 (ko) 2024-11-14
NZ745808A (en) 2024-09-27
CA3015150A1 (en) 2017-09-14
CN118441040A (zh) 2024-08-06
RU2018135107A (ru) 2020-04-08
EP3712280B1 (en) 2023-08-09
AU2017231845B2 (en) 2023-09-28
US12467095B2 (en) 2025-11-11
EP3574117A1 (en) 2019-12-04
KR102618993B1 (ko) 2023-12-28
KR20240011189A (ko) 2024-01-25
US20190085395A1 (en) 2019-03-21
JP2022163063A (ja) 2022-10-25
ES2965297T3 (es) 2024-04-12
US20260049358A1 (en) 2026-02-19
CN116004796A (zh) 2023-04-25
HK1258615A1 (zh) 2019-11-15
CA3050996A1 (en) 2018-08-02
ES3075550T3 (en) 2026-08-05
EP4403649A2 (en) 2024-07-24
EP3712277C0 (en) 2024-06-12
JP2020511953A (ja) 2020-04-23
EP3426796A1 (en) 2019-01-16
US11414705B2 (en) 2022-08-16
WO2017153710A1 (en) 2017-09-14
KR20240167935A (ko) 2024-11-28
BR112018067882A2 (pt) 2019-02-05
JP7111619B2 (ja) 2022-08-02
WO2018138468A1 (en) 2018-08-02
KR102920553B1 (ko) 2026-01-30

Similar Documents

Publication Publication Date Title
BR112019002665A2 (enExample)
BR112018004986A2 (enExample)
BR112019001429A2 (enExample)
BR112019008087A2 (enExample)
BR212018070320U2 (enExample)
BR112019011044B1 (pt) Compostos de pirazol substituído, seu uso, e composição farmacêutica
BR112019008501B1 (pt) Método realizado por um equipamento de usuário, método realizado por um nó de rede, equipamento de usuário, nó de rede, e, meios de armazenamento legíveis por computador
BR112019003548B1 (pt) Método de comunicação sem fio realizado por um equipamento de usuário (ue), aparelho, e, memória
BR112019003116B1 (pt) Configuração de símbolo de rajada comum de uplink
BR112018076493B1 (pt) Sistemas e métodos para detecção de posição de feixe de luz
BR112018073794B1 (pt) Partícula, método de geração da partícula, vacina ou composição farmacêutica
BR112018072248B1 (pt) Proteína gp140 do envelope de hiv-1 modificada, seu uso, e composição de vacina contra hiv-1
BR122026002520A2 (pt) Célula, conjunto de vetores para expressar uma proteína de ligação a antígeno biespecífica em uma célula, conjunto de vetores, sistema, método, e, método para produção de uma proteína de ligação a antígeno
BR112018071153B1 (pt) Anticorpo anti-vista humano, seu uso e composição farmacêutica ou para diagnóstico
BR112019006736A2 (enExample)
CN303644332S (zh) 操作台(czt100)
CN303628467S (zh) 气体罐装器
CN303569957S (zh) 四斗柜(66273h)
CN303550703S (zh) Usb充电排插
CN303615382S (zh) 无纺布(一字纹)
CN303608264S (zh) 全自动一体面条机
CN303579377S (zh) 发动机曲轴后油封总成(c10t)
CN303536045S (zh) 嫁衣(15)
CN303535546S (zh) 冰棒(北极兔雪糕冰棒)
CN303536541S (zh) 相机用挂带